Heart Rate Variability and Diabetic Kidney Disease in Type 2 Diabetes Mellitus Patients

Sponsor
Shi wei, MM (Other)
Overall Status
Completed
CT.gov ID
NCT02996539
Collaborator
(none)
392
1
25.9
15.1

Study Details

Study Description

Brief Summary

Several studies have investigated an association between cardiac autonomic neuropathy (CAN) and albuminuria, glomerular filtration rate, or both, and hypothesized that CAN is involved in the pathogenesis of nephropathy. However, most of these studies had focused on Caucasians and were limited to a small number of patients with type 1 diabetes mellitus, or had used a conventional Ewing battery of tests based on dynamic cardiovascular maneuvers.Yet, there is consistent data showing that Asian diabetic populations, including the Chinese, have a higher risk of renal complications than Caucasians do.

The present study investigated an association between heart rate variability (HRV) parameters and diabetic kidney disease (DKD) in Chinese type 2 diabetes mellitus (T2DM) patients, specifically through time and frequency domain analyses of HRV and urine albumin creatinine ratio (UACR) or estimated glomerular filtration rate (eGFR).

Condition or Disease Intervention/Treatment Phase
  • Other: Clinical examination and laboratory measurements

Detailed Description

present study investigated an association between HRV parameters and DKD in Chinese T2DM patients, specifically through time and frequency domain analyses of HRV and UACR or eGFR

Study Design

Study Type:
Observational
Actual Enrollment :
392 participants
Observational Model:
Case-Only
Official Title:
Heart Rate Variability and Diabetic Kidney Disease in Type 2 Diabetes Mellitus Patients
Study Start Date :
Feb 1, 2013
Actual Primary Completion Date :
Apr 1, 2015
Actual Study Completion Date :
Apr 1, 2015

Arms and Interventions

Arm Intervention/Treatment
Type 2 diabetes

With Clinical examination and laboratory measurements

Other: Clinical examination and laboratory measurements
Subjects were interviewed by a physician regarding their medical history, history of hypoglycemic attacks, smoking status, and alcohol consumption. Concentrations of blood urea nitrogen (BUN) and serum creatinine (SCr) were analyzed by the urease-ultraviolet rate method and picric acid method, respectively. Serum uric acid was determined using the enzymatic colorimetric method. Serum hemoglobin A1c (HbA1c) was measured by liquid enzymatic assay. Urine albumin and urine creatinine were found through immune turbidimetric analysis and the enzymatic method, respectively.
Other Names:
  • Physical examination and blood urine samples collection
  • Outcome Measures

    Primary Outcome Measures

    1. Association between HRV and renal function (eGFR and UACR) [1week]

      Assessment of HRV HRV measurement based on 24-hour ambulatory ECG monitoring was obtained from all patients using a 3- channel digital Holter recorder (CB-2302-A, Wuxi, Jiangsu, China). Assessment of DKD DKD was defined as the presence of albuminuria (UACR ≥ 30 mg/g,urine albumin in milligram,creatinine in gram) or eGFR < 60 mL/min/1.73 m^2 (creatinine concentration in umol/l,creatinine molecular weight in micromole, volume in litre;urine volume per minute in milliliter per minute; body surface area in square meter) based on SCr levels. Albuminuria was defined using UACR of a single early-morning urine measurement.For all Participants, 132 patients had albuminuria and 50 patients with eGFR < 60 mL/min/1.73 m^2

    Secondary Outcome Measures

    1. Clinical characteristics of patients [1week]

      Clinical examination and laboratory measurements Subjects were interviewed by a physician regarding their medical history, history of hypoglycemic attacks, smoking status, and alcohol consumption. A trained examiner measured the height (in meters) and body weight (in kilograms) of the patients. Body mass index (BMI) in kg/m^2, weight in kilograms, height in meters. Hypertension was defined as systolic blood pressure ≥140 mm Hg or diastolic blood pressure ≥90 mm Hg, or both, or if the patient was already taking anti-hypertensive drugs. Blood and urine samples were analyzed at the medical examination center of Kunming First People's Hospital.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 80 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Clinical diagnosis of T2DM

    • Adult patients has had consecutively undergone 24-hour Holter monitoring for heart rate variability analysis

    Exclusion Criteria:
    • Patients with acute complications of DM including diabetic ketoacidosis, hyperosmolar coma

    • Foot ulcer

    • Severe acute or chronic infection

    • Chronic liver disease

    • Dialysis or renal transplantation

    • The presence of any serious concomitant disease affecting life expectancy were not eligible for the study.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Internal medicine department, Kunming First People's Hospital Kunming Yunnan China 650000

    Sponsors and Collaborators

    • Shi wei, MM

    Investigators

    • Study Chair: Xiaolei Chen, MM, Kunming first people's hospital

    Study Documents (Full-Text)

    None provided.

    More Information

    Additional Information:

    Publications

    Responsible Party:
    Shi wei, MM, Director, First People's Hospital of Kunming
    ClinicalTrials.gov Identifier:
    NCT02996539
    Other Study ID Numbers:
    • FirstPHKunming
    First Posted:
    Dec 19, 2016
    Last Update Posted:
    Dec 19, 2016
    Last Verified:
    Dec 1, 2016
    Individual Participant Data (IPD) Sharing Statement:
    Yes
    Plan to Share IPD:
    Yes
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Dec 19, 2016